{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "22837039",
  "DateCompleted": {
    "Year": "2012",
    "Month": "10",
    "Day": "25"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "10",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2012",
        "Month": "07",
        "Day": "26"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1038/nn.3159"
    ],
    "Journal": {
      "ISSN": "1546-1726",
      "JournalIssue": {
        "Volume": "15",
        "Issue": "8",
        "PubDate": {
          "Year": "2012",
          "Month": "Jul",
          "Day": "26"
        }
      },
      "Title": "Nature neuroscience",
      "ISOAbbreviation": "Nat Neurosci"
    },
    "ArticleTitle": "Neural circuitry engaged by prostaglandins during the sickness syndrome.",
    "Pagination": {
      "StartPage": "1088",
      "EndPage": "1095",
      "MedlinePgn": "1088-95"
    },
    "Abstract": {
      "AbstractText": [
        "During illnesses caused by infectious disease or other sources of inflammation, a suite of brain-mediated responses called the sickness syndrome occurs, which includes fever, anorexia, sleepiness, hyperalgesia and elevated corticosteroid secretion. Much of the sickness syndrome is mediated by prostaglandins acting on the brain and can be prevented by nonsteroidal anti-inflammatory drugs, such as aspirin or ibuprofen, that block prostaglandin synthesis. By examining which prostaglandins are produced at which sites and how they interact with the nervous system, researchers have identified specific neural circuits that underlie the sickness syndrome."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Neurology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. csaper@bidmc.harvard.edu"
          }
        ],
        "LastName": "Saper",
        "ForeName": "Clifford B",
        "Initials": "CB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Romanovsky",
        "ForeName": "Andrej A",
        "Initials": "AA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Scammell",
        "ForeName": "Thomas E",
        "Initials": "TE"
      }
    ],
    "GrantList": [
      {
        "GrantID": "HL095491",
        "Acronym": "HL",
        "Agency": "NHLBI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 NS041233",
        "Acronym": "NS",
        "Agency": "NINDS NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 NS055367",
        "Acronym": "NS",
        "Agency": "NINDS NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "NS072337",
        "Acronym": "NS",
        "Agency": "NINDS NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "NS41233",
        "Acronym": "NS",
        "Agency": "NINDS NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "P01 HL095491",
        "Acronym": "HL",
        "Agency": "NHLBI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 NS072337",
        "Acronym": "NS",
        "Agency": "NINDS NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "NS055367",
        "Acronym": "NS",
        "Agency": "NINDS NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Nat Neurosci",
    "NlmUniqueID": "9809671",
    "ISSNLinking": "1097-6256"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Inflammatory Agents, Non-Steroidal"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Prostaglandins"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "pharmacology",
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Inflammatory Agents, Non-Steroidal"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology",
        "pathology"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy",
        "physiopathology"
      ],
      "DescriptorName": "Inflammation"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Prostaglandins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Syndrome"
    }
  ]
}